Preliminary PET/CT Imaging with Somatostatin Analogs [68Ga]DOTAGA-TATE and [68Ga]DOTAGA-TOC.

about

Preliminary PET/CT Imaging with Somatostatin Analogs [68Ga]DOTAGA-TATE and [68Ga]DOTAGA-TOC.

Item

http://www.wikidata.org/entity/Q48353671

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Preliminary PET/CT Imaging wit ...... AGA-TATE and [68Ga]DOTAGA-TOC.

@en

Preliminary PET/CT Imaging wit ...... AGA-TATE and [68Ga]DOTAGA-TOC.

@nl

type

Item

label

Preliminary PET/CT Imaging wit ...... AGA-TATE and [68Ga]DOTAGA-TOC.

@en

Preliminary PET/CT Imaging wit ...... AGA-TATE and [68Ga]DOTAGA-TOC.

@nl

prefLabel

Preliminary PET/CT Imaging wit ...... AGA-TATE and [68Ga]DOTAGA-TOC.

@en

Preliminary PET/CT Imaging wit ...... AGA-TATE and [68Ga]DOTAGA-TOC.

@nl

P1476

Preliminary PET/CT Imaging wit ...... AGA-TATE and [68Ga]DOTAGA-TOC.

@en

P2093

Ajit Shinto

http://www.w3.org/2001/XMLSchema#string

Ashutosh Dash

http://www.w3.org/2001/XMLSchema#string

K K Kamaleshwaran

http://www.w3.org/2001/XMLSchema#string

P2860

[(68)Ga]NODAGA-RGD - Metabolic stability, biodistribution, and dosimetry data from patients with hepatocellular carcinoma and liver cirrhosis

Effects of chelator modifications on (68)Ga-labeled [Tyr (3)]octreotide conjugates.

Twins in spirit - episode I: comparative preclinical evaluation of [(68)Ga]DOTATATE and [(68)Ga]HA-DOTATATE

Rapid kit-based (68)Ga-labelling and PET imaging with THP-Tyr(3)-octreotate: a preliminary comparison with DOTA-Tyr(3)-octreotate

Glucagon-Like Peptide-1 Receptor PET/CT with 68Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study.

PET/CT with 68Gallium-DOTA-peptides in NET: an overview.

Gallium-68: chemistry and radiolabeled peptides exploring different oncogenic pathways.

68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies.

Benefits of NOPO as chelator in gallium-68 peptides, exemplified by preclinical characterization of (68)Ga-NOPO-c(RGDfK).

Pharmacokinetic properties of peptidic radiopharmaceuticals: reduced uptake of (EH)3-conjugates in important organs.

P2888

s11307-017-1072-z

P304

878-884

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11307-017-1072-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Haladhar Dev Sarma

Drishty Satpati

P577

2017-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28349291

http://www.w3.org/2001/XMLSchema#string